General Information
Drug ID
DR01431
Drug Name
Famciclovir
Synonyms
FCV; Famciclovirum; Famvir; Oravir; BRL 42810; IN1338; Anti-Farnesyl Rabbit pAb; BRL-42810; Famciclovirum [INN-Latin]; Famvir (TN); Famciclovir [USAN:BAN:INN]; Famciclovir (JAN/USAN/INN); [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate; Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine; 1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester); 2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester); 2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate; 2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate; 2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate; 2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate; 9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine; 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
Drug Type
Small molecular drug
Indication Viral infections [ICD11: 1D90-1D9Z] Approved [1]
Therapeutic Class
Antiviral Agents
Structure
3D MOL 2D MOL
Formula
C14H19N5O4
Canonical SMILES
CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
InChI
InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)
InChIKey
GGXKWVWZWMLJEH-UHFFFAOYSA-N
CAS Number
CAS 104227-87-4
Pharmaceutical Properties Molecular Weight 321.33 Topological Polar Surface Area 122
Heavy Atom Count 23 Rotatable Bond Count 9
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 8
XLogP
0
PubChem CID
3324
PubChem SID
626303 , 5276651 , 7847383 , 7979216 , 8152111 , 11363360 , 11365922 , 11368484 , 11372808 , 11374301 , 11376646 , 11484938 , 11488917 , 11491490 , 11492426 , 11494280 , 11528705 , 12013946 , 14899331 , 26612822 , 26680213 , 26719883 , 26748972 , 26748973 , 26758694 , 29222459 , 46386745 , 46507561 , 47291220 , 47515410 , 48415997 , 49681753 , 50107498 , 52712677 , 53800778 , 56313627 , 57321725 , 68530529 , 81092805 , 85173809 , 85787983 , 92124793 , 92308042 , 92308372 , 92309126 , 92710468 , 103158204 , 103231964 , 104253634 , 104303176
ChEBI ID
CHEBI:4974
TTD Drug ID
D0VT8P
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Famciclovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Ther. 2002 Dec;303(3):1029-37.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.